GlobalData
GlobalData

Press Release

World Cancer Day: What will 2018 mean for cancer research and treatment?

The theme of this year’s World Cancer Day held on 4th February of “We can. I can.” aimed to reinforce the public message that all individuals and groups can play their part in reducing the global burden of cancer. Indeed in recent years many events have involved collaborations between traditional drug developers, cancer treatment professionals and those of varying disciplines. Examples include the IBM Watson supercomputer which is helping physicians make treatment decisions and the development of other databases such as ASCO’s CancerLinQ which assists oncologists in monitoring and analyzing patient data.
Read more

Digital technology should complement rather than replace face-to-face customer interaction in retail, says GlobalData

As technology is becoming a major competitive differentiator, retailers should look to complement traditional ways of customer interaction rather than completely replacing them to provide a successful omnichannel experience, says leading data and analytics company GlobalData. Technology has transformed how retailers operate, connect with and provide services to customers. Retailers are integrating customer records, interaction […]
Read more

Amazon, Berkshire Hathaway and JP Morgan healthcare announcement, comment from GlobalData

The announcement on Tuesday 30th January 2018 that Amazon, Berkshire Hathaway and JPMorgan are investigating ways to make health care more affordable and effective for employees and patients alike is a significant step in the intersection between health, tech and insurance. Jim Miller, President PharmSource, A GlobalData Company said: ”In their announcement the founders said […]
Read more

Local retailers in Australia need to invest in technology to compete with Amazon, says GlobalData

Amazon’s ambitious foray into Australia may push local retailers to focus on segment-specific knowledge and invest in technology for survival, says leading data and analytics company GlobalData. Online retailer Amazon, which had long kept Australia on low priority list while expanding into less developed and smaller countries, finally launched its Australian e-commerce platform late last […]
Read more

Premium beer consumption in Vietnam more than doubled between 2011 and 2016

A storm is brewing for discount brands selling lower-quality products as Vietnamese beer drinkers are increasingly picking up premium and superpremium products from shelves, with premium beer consumption rocketing to 10 million hectoliters in 2016, according to GlobalData, a leading data and analytics company. GlobalData’s latest report ‘Vietnam Beer and Cider Market Insights 2017’ states […]
Read more

Yakult shows how breaking with tradition can attract new consumer segments

Long-established brands like Yakult have demonstrated how to win consumer attention by being open-minded during product development, accommodative to changing consumer trends and bold enough to take risks in breaking brand tradition, according to GlobalData, a leading data and analytics company. GlobalData’s latest report ‘Success Case Study: Everyday Yakult Probiotic Dairy Drink’ draws attention to […]
Read more

Paradise Papers: wealth managers must brace for more regulation

The Paradise Papers are likely to cause little in the way of direct implications for offshore wealth managers in Asia-Pacific, according to an analyst with GlobalData, a leading data and analytics company. Andrew Haslip, Financial Services Head of Content for Asia-Pacific, says that all the latest release will do is stoke more political appetite for […]
Read more

What impact will repealing the ACA have on expanded Medicaid coverage

In October 2017, the Republican Party opted not to present its most recent healthcare bill, the Graham-Cassidy Bill, to the US Senate, once again halting its efforts to repeal the Affordable Care Act (ACA). As the latest attempt of many to replace the ACA, the bill has been highly controversial. Among the most debated measures in the bill is a provision for changing the federal government’s funding scheme for Medicaid programs, designed to restrict the potential for increases in federal spending on Medicaid.
Read more
1 51 52 53 54 55 61